NCT00962143撤回不适用
Prospective, Randomized, Multi-center: Acute Achilles Repair With or Without OrthADAPT Augmentation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- Time to return to full activity
研究概览
简要总结
The purpose of this study is to assess the clinical performance of the OrthADAPT Bioimplant in patients with acute mid-substance Achilles tendon tears requiring surgical repair.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •A transverse, full thickness, acute mid-substance Achilles tendon tear that requires surgical repair
- •Achilles tendon tear is repairable by surgery using primary means as determined by intra-operative assessment
- •Achilles tendon rupture with viable ends of the tendon that are suitable for primary repair
- •Isolated Achilles tendon rupture without poly trauma
- •Patient must be 18 to 70 years of age
- •Life expectancy greater than or equal to 12 months
- •Patient is able to provide voluntary informed consent
- •Patient is willing and able to return for all follow-up visits and study related exams
- •Patient is willing to comply with prescribed physical therapy regimen
排除标准
- •Emergency, poly trauma patients
- •Previous Achilles tendon surgical procedure on that tendon
- •Deficit in the contralateral extremity that prevents a comparison with the treated extremity
- •Repair requires tendon lengthening, gap filling or tendon transfer
- •BMI greater than 40
- •Peripheral arterial disease
- •Uncontrolled Diabetes Mellitis
- •Patients whose injury is known to involve litigation
- •Known allergy to equine derived product
- •Systemic collagen disease
- •Neurological disease
- •Active infection - systemic or at the intended surgical site
- •Acute use of immunosuppressive agents
- •Rupture resulting from fluoroquinolone induced tendinopathy
- •Alcohol or drug abuse
- •Participant in another investigational drug or device trial
- •Pathologic soft tissue conditions that would prevent secure surgical fixation
- •Patients who are unwilling or unable to return for follow-up visits and study related exams
- •Pregnant women
- •Cancer patients
- •Decisionally impaired patients
- •Institutionalized patients
- •Prisoners
结局指标
主要结局
Time to return to full activity
时间窗: 2, 3, 4.5, 6, and 12 months
Improvement in ROM and Biodex Isokinetic Strength Testing compared to contralateral limb
时间窗: 2, 3, 4.5, 6, and 12 months
Time to return to weight bearing
时间窗: 2, 3, 4.5, 6, and 12 months
次要结局
- Complication rate including re-rupture and incision wound healing delay(6 weeks, 2, 3, 4.5, 6 and 12 months)
- Incidence of device and procedure-related adverse events(6 weeks, 2, 3, 4.5, 6 and 12 months)
- Swelling, stiffness, pain, disease specific quality of life: SF-36, AOFAS Hindfoot scores(6 weeks, 2, 3, 4.5, 6 and 12 months)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Clinical Evaluation of the OrthoPAT Advance SystemTransmission, Blood, Recipient/DonorNCT01756976Haemonetics Corporation84
已完成
不适用
Autologous Chondrocyte Implantation in the Patellofemoral JointChondrosisPatellar Articular Cartilage LesionsTrochlear Articular Cartilage LesionsNCT00212849Orthopaedic Research Foundation35
已完成
不适用
High Volume Injection or Autologous Conditioned Plasma (ACP) in Chronic Achilles TendinopathyTendinopathyNCT02417987Bispebjerg Hospital60
已完成
不适用
Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients.Degenerative ArthritisKnee OsteoarthritisNCT03000712R-Bio26
已完成
不适用
Platelet Rich Plasma vs Hyaluronic-Acid in Hip OA (Osteoarthritis)Hip OsteoarthritisNCT01920152University of Colorado, Denver38